These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 21354461)
1. Suppression of estrogen actions in human lung cancer. Miki Y; Abe K; Suzuki S; Suzuki T; Sasano H Mol Cell Endocrinol; 2011 Jul; 340(2):168-74. PubMed ID: 21354461 [TBL] [Abstract][Full Text] [Related]
2. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma. Niikawa H; Suzuki T; Miki Y; Suzuki S; Nagasaki S; Akahira J; Honma S; Evans DB; Hayashi S; Kondo T; Sasano H Clin Cancer Res; 2008 Jul; 14(14):4417-26. PubMed ID: 18579664 [TBL] [Abstract][Full Text] [Related]
3. Aromatase in human lung carcinoma. Verma MK; Miki Y; Sasano H Steroids; 2011 Jul; 76(8):759-64. PubMed ID: 21392519 [TBL] [Abstract][Full Text] [Related]
4. Intratumoral localization of aromatase and interaction between stromal and parenchymal cells in the non-small cell lung carcinoma microenvironment. Miki Y; Suzuki T; Abe K; Suzuki S; Niikawa H; Iida S; Hata S; Akahira J; Mori K; Evans DB; Kondo T; Yamada-Okabe H; Sasano H Cancer Res; 2010 Aug; 70(16):6659-69. PubMed ID: 20710045 [TBL] [Abstract][Full Text] [Related]
5. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario. Carruba G J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930 [TBL] [Abstract][Full Text] [Related]
6. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. Schwartz AG; Wenzlaff AS; Prysak GM; Murphy V; Cote ML; Brooks SC; Skafar DF; Lonardo F J Clin Oncol; 2007 Dec; 25(36):5785-92. PubMed ID: 18089876 [TBL] [Abstract][Full Text] [Related]
7. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Stabile LP; Davis AL; Gubish CT; Hopkins TM; Luketich JD; Christie N; Finkelstein S; Siegfried JM Cancer Res; 2002 Apr; 62(7):2141-50. PubMed ID: 11929836 [TBL] [Abstract][Full Text] [Related]
8. Aromatase inhibitors in human lung cancer therapy. Weinberg OK; Marquez-Garban DC; Fishbein MC; Goodglick L; Garban HJ; Dubinett SM; Pietras RJ Cancer Res; 2005 Dec; 65(24):11287-91. PubMed ID: 16357134 [TBL] [Abstract][Full Text] [Related]
9. Highly concordant coexpression of aromatase and estrogen receptor beta in non-small cell lung cancer. Abe K; Miki Y; Ono K; Mori M; Kakinuma H; Kou Y; Kudo N; Koguchi M; Niikawa H; Suzuki S; Evans DB; Sugawara S; Suzuki T; Sasano H Hum Pathol; 2010 Feb; 41(2):190-8. PubMed ID: 19800101 [TBL] [Abstract][Full Text] [Related]
10. Co-expression of estrogen receptor beta and aromatase in Japanese lung cancer patients: gender-dependent clinical outcome. Verma MK; Miki Y; Abe K; Nagasaki S; Niikawa H; Suzuki S; Kondo T; Sasano H Life Sci; 2012 Oct; 91(15-16):800-8. PubMed ID: 22982181 [TBL] [Abstract][Full Text] [Related]
11. Intratumoral estrogen production in breast carcinoma: significance of aromatase. Suzuki T; Miki Y; Ohuchi N; Sasano H Breast Cancer; 2008; 15(4):270-7. PubMed ID: 18622573 [TBL] [Abstract][Full Text] [Related]
12. In situ estrogen production and its regulation in human breast carcinoma: from endocrinology to intracrinology. Sasano H; Miki Y; Nagasaki S; Suzuki T Pathol Int; 2009 Nov; 59(11):777-89. PubMed ID: 19883428 [TBL] [Abstract][Full Text] [Related]
13. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma. Utsunomiya H; Ito K; Suzuki T; Kitamura T; Kaneko C; Nakata T; Niikura H; Okamura K; Yaegashi N; Sasano H Clin Cancer Res; 2004 Sep; 10(17):5850-6. PubMed ID: 15355916 [TBL] [Abstract][Full Text] [Related]
14. Estrogen receptors (alpha and beta) and 17beta-hydroxysteroid dehydrogenase type 1 and 2 in thyroid disorders: possible in situ estrogen synthesis and actions. Kawabata W; Suzuki T; Moriya T; Fujimori K; Naganuma H; Inoue S; Kinouchi Y; Kameyama K; Takami H; Shimosegawa T; Sasano H Mod Pathol; 2003 May; 16(5):437-44. PubMed ID: 12748250 [TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic estrogen receptor β as a potential marker in human non-small cell lung carcinoma. Verma MK; Miki Y; Abe K; Niikawa H; Sasano H Expert Opin Ther Targets; 2012 Mar; 16 Suppl 1():S91-102. PubMed ID: 22313325 [TBL] [Abstract][Full Text] [Related]
16. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells. Miki Y; Suzuki T; Tazawa C; Yamaguchi Y; Kitada K; Honma S; Moriya T; Hirakawa H; Evans DB; Hayashi S; Ohuchi N; Sasano H Cancer Res; 2007 Apr; 67(8):3945-54. PubMed ID: 17440110 [TBL] [Abstract][Full Text] [Related]
17. Expression of estrogen and progesterone receptors in non-small-cell lung cancer: immunohistochemical study. Su JM; Hsu HK; Chang H; Lin SL; Chang HC; Huang MS; Tseng HH Anticancer Res; 1996; 16(6B):3803-6. PubMed ID: 9042261 [TBL] [Abstract][Full Text] [Related]
18. Progesterone receptor in non-small cell lung cancer--a potent prognostic factor and possible target for endocrine therapy. Ishibashi H; Suzuki T; Suzuki S; Niikawa H; Lu L; Miki Y; Moriya T; Hayashi S; Handa M; Kondo T; Sasano H Cancer Res; 2005 Jul; 65(14):6450-8. PubMed ID: 16024650 [TBL] [Abstract][Full Text] [Related]
19. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. Pasqualini JR; Chetrite GS J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265 [TBL] [Abstract][Full Text] [Related]
20. Aromatase in the context of breast and endometrial cancer. A review. Jongen VH; Hollema H; Van Der Zee AG; Heineman MJ Minerva Endocrinol; 2006 Mar; 31(1):47-60. PubMed ID: 16498363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]